Verde Servicos Internacionais S.A. Sage Therapeutics, Inc. Transaction History

Verde Servicos Internacionais S.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 14, 2019	SELL	$81.94 - $139.71 $2.26 Million - $3.85 Million	-27,552 Closed	0 $0
Q3 2018 Oct 03, 2018	SELL	$138.11 - $169.04 $531,861 - $650,973	-3,851 Reduced 12.26%	27,552 $4.31 Million
Q2 2018 Jul 05, 2018	SELL	$140.36 - $175.76 $732,819 - $917,642	-5,221 Reduced 14.26%	31,403 $4.92 Million
Q1 2018 Apr 13, 2018	BUY	$152.15 - $192.33 $5.57 Million - $7.04 Million	36,624 New	36,624 $5.9 Million

216

47.8M

854K

195K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $353M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Verde Servicos Internacionais S.A., based on Form 13F filings with the SEC.

Stay updated on Verde Servicos Internacionais S.A. with notifications on news.